Genotyping Market Trends, Growth and Insights by Technology (Sequencing, Capillary Electrophoresis, PCR, and Others), Product (Reagents and Kits and Others), Application (Diagnostics and Others), End-User (Hospitals, Diagnostic Centers), and Region-Forecast till 2027
ID: MRFR/LS/5172-HCR | February 2021 | Region: Global | 85 Pages
Table of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Genotyping Market, by Technology
6.1 Introduction
6.2 Sequencing
6.2.1 Next-Generation Sequencing
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.2 Pyrosequencing
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.3 Sanger Sequencing
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3 Capillary Electrophoresis
6.3.1 Amplified Fragment Length Polymorphism (AFLP)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3.2 Single-Strand Conformation Polymorphism (SSCP)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3.3 Restriction Fragment Length Polymorphism (RFLP
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4 PCR
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.5 Microarray
6.5.1 DNA microarrays
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.5.2 Antibody microarrays
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.5.3 MMChips
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.5.4 Peptide microarrays
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.6 Mass Spectrometry
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 7. Global Genotyping Market, by Product
7.1 Introduction
7.2 Reagents And Kits
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3 Instruments
7.3.1 Sequencer
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3.2 Amplifiers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4 Services
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 8. Global Genotyping Market, by Application
8.1 Introduction
8.2 Diagnostics
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3 Drug Discovery And Development
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4 Agriculture
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.5 Academic Research
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.6 Personalized Medicine
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 9. Global Genotyping Market, by End-User
9.1 Introduction
9.2 Hospitals
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.3 Diagnostic Centers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.4 Academic Institutes
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.5 Research and Development Centers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.6 Personalized Medicine
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 10. Global Genotyping Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
Chapter 12. Company Profiles
12.1 QIAGEN
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials Overview
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.2 Affymetrix, Inc.
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Illumina, Inc
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Thermo Fisher Scientific, Inc.
12.4.1 Company Overview
12.4.2 Technology/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 GENERAL ELECTRIC COMPANY
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 Agilent Technologies, Inc.
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.7 Fluidigm Corporation
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financial Overview
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Sequenom
12.8.1 Overview
12.8.2 Product/ Technology Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 F. Hoffmann-La Roche Ltd
12.9.1 Overview
12.9.2 Product Overview
12.9.3 Financials
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.10 Beckman Coulter, Inc.
12.10.1 Overview
12.10.2 Product Overview
12.10.3 Financials
12.10.4 Key Developments
12.10.5 SWOT Analysis
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s Viewpoint
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Predictions for the Genotyping Industry
Chapter 14. Appendix
LIST OF TABLES
Table 1 Global Genotyping Market Synopsis, 2020-2027
Table 2 Global Genotyping Market Estimates and Forecast, 2020-2027 (USD Million)
Table 3 Global Genotyping Market, by Region, 2020-2027 (USD Million)
Table 4 Global Genotyping Market, by Technology 2020-2027 (USD Million)
Table 5 Global Genotyping Market, by Product, 2020-2027 (USD Million)
Table 6 Global Genotyping Market, by End-User, 2020-2027 (USD Million)
Table 7 Global Genotyping Market, by Application, 2020-2027 (USD Million)
Table 8 North America: Genotyping Market, by Technology, 2020-2027 (USD
Million)
Table 9 North America: Genotyping Market, by Product, 2020-2027 (USD
Million)
Table 10 North America: Genotyping Market, by Application, 2020-2027 (USD
Million)
Table 11 North America: Genotyping Market, by End-User, 2020-2027 (USD
Million)
Table 12 US: Genotyping Market, by Technology, 2020-2027 (USD Million)
Table 13 US: Genotyping Market, by Product, 2020-2027 (USD Million)
Table 14 US: Genotyping Market, by Application, 2020-2027 (USD Million)
Table 15 US: Genotyping Market, by End-User, 2020-2027 (USD Million)
Table 16 Canada: Genotyping Market, by Technology, 2020-2027 (USD Million)
Table 17 Canada: Genotyping Market, by Product, 2020-2027 (USD Million)
Table 18 Canada: Genotyping Market, by Application, 2020-2027 (USD
Million)
Table 19 Canada: Genotyping Market, by End-User, 2020-2027 (USD
Million)
Table 20 South America: Genotyping Market, by Technology, 2020-2027 (USD
Million)
Table 21 South America: Genotyping Market, by Product, 2020-2027 (USD
Million)
Table 22 South America: Genotyping Market, by Application, 2020-2027 (USD
Million)
Table 23 South America: Genotyping Market, by End-User, 2020-2027 (USD
Million)
Table 24 Europe: Genotyping Market, by Technology, 2020-2027 (USD Million)
Table 25 Europe: Genotyping Market, by Product, 2020-2027 (USD Million)
Table 26 Europe: Genotyping Market, by Application, 2020-2027 (USD Million)
Table 27 Europe: Genotyping Market, by End-User, 2020-2027 (USD Million)
Table 28 Western Europe: Genotyping Market, by Technology, 2020-2027 (USD
Million)
Table 29 Western Europe: Genotyping Market, by Product, 2020-2027 (USD
Million)
Table 30 Western Europe: Genotyping Market, by Application, 2020-2027
(USD Million)
Table 31 Western Europe: Genotyping Market, by End-User, 2020-2027
(USD Million)
Table 32 Eastern Europe: Genotyping Market, by Technology, 2020-2027 (USD
Million)
Table 33 Eastern Europe: Genotyping Market, by Product, 2020-2027 (USD
Million)
Table 34 Eastern Europe: Genotyping Market, by Application, 2020-2027
(USD Million)
Table 35 Eastern Europe: Genotyping Market, by End-User, 2020-2027
(USD Million)
Table 36 Asia-Pacific: Genotyping Market, by Technology, 2020-2027 (USD
Million)
Table 37 Asia-Pacific: Genotyping Market, by Product, 2020-2027 (USD
Million)
Table 38 Asia-Pacific: Genotyping Market, by Application, 2020-2027 (USD
Million)
Table 39 Asia-Pacific: Genotyping Market, by End-User, 2020-2027 (USD
Million)
Table 40 Middle East & Africa: Genotyping Market, by Technology, 2020-2027
(USD Million)
Table 41 Middle East & Africa: Genotyping Market, by Product, 2020-2027
(USD Million)
Table 42 Middle East & Africa: Genotyping Market, by Application, 2020-2027
(USD Million)
Table 43 Middle East & Africa: Genotyping Market, by End-User, 2020-2027
(USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Genotyping Market
Figure 3 Segmentation Market Dynamics for Global Genotyping Market
Figure 4 Global Genotyping Market Share, by Technology , 2020
Figure 5 Global Genotyping Market Share, by Product, 2020
Figure 6 Global Genotyping Market Share, by Application, 2020
Figure 7 Global Genotyping Market Share, by End-User, 2020
Figure 8 Global Genotyping Market Share, by Region, 2020
Figure 9 North America: Genotyping Market Share, by Country, 2020
Figure 10 Europe: Genotyping Market Share, by Country, 2020
Figure 11 Asia-Pacific: Genotyping Market Share, by Country, 2020
Figure 12 Middle East & Africa: Genotyping Market Share, by Country, 2020
Figure 13 Global Genotyping Market: Company Share Analysis, 2020 (%)
Figure 14 QIAGEN : Key Financials
Figure 15 QIAGEN : Segmental Revenue
Figure 16 QIAGEN : Geographical Revenue
Figure 17 Affymetrix, Inc.: Key Financials
Figure 18 Affymetrix, Inc.: Segmental Revenue
Figure 19 Affymetrix, Inc.: Geographical Revenue
Figure 20 Illumina, Inc: Key Financials
Figure 21 Illumina, Inc: Segmental Revenue
Figure 22 Illumina, Inc: Geographical Revenue
Figure 23 Thermo Fisher Scientific, Inc.: Key Financials
Figure 23 Thermo Fisher Scientific, Inc.: Segmental Revenue
Figure 25 Thermo Fisher Scientific, Inc.: Geographical Revenue
Figure 26 GENERAL ELECTRIC COMPANY: Key Financials
Figure 27 GENERAL ELECTRIC COMPANY: Segmental Revenue
Figure 28 GENERAL ELECTRIC COMPANY. Geographical Revenue
Figure 29 Agilent Technologies, Inc.: Key Financials
Figure 30 Agilent Technologies, Inc.: Segmental Revenue
Figure 31 Agilent Technologies, Inc.: Geographical Revenue
Figure 32 Fluidigm Corporation : Key Financials
Figure 33 Fluidigm Corporation : Segmental Revenue
Figure 34 Fluidigm Corporation : Geographical Revenue
Figure 35 Sequenom: Key Financials
Figure 36 Sequenom: Segmental Revenue
Figure 37 Sequenom: Geographical Revenue
Figure 38 F. Hoffmann-La Roche Ltd: Key Financials
Figure 39 F. Hoffmann-La Roche Ltd: Segmental Revenue
Figure 40 F. Hoffmann-La Roche Ltd: Geographical Revenue
Figure 41 Beckman Coulter, Inc.: Key Financials
Figure 42 Beckman Coulter, Inc.: Segmental Revenue
Figure 43 Beckman Coulter, Inc.: Geographical Revenue
Genotyping Market
The genotyping market accounted for USD 6520 million and expected to register healthy growth CAGR 23.89% by 2027
$6520 million
Market Size
23.89%
CAGR
North America
Dominating Region
2020-2027
Forecast Period
Segmentation
Key Players
- QIAGEN
- Affymetrix
- Illumina
- Thermo Fisher Scientific
- General Electric Company
- Agilent Technologies
- Fluidigm Corporation
- Sequenom
- F. Hoffmann-La Roche Ltd
- Beckman Coulter
Drivers
- Rising prevalence of genetic diseases
Genotyping Market Scenario
The genotyping market accounted for USD 6120 million in 2015 and expected to register healthy growth during the forecast period (2018–2023) at a CAGR of 22.5%.
Genotyping services help to understand the genetic structure of any living organisms such as humans, animals, plants, and microorganisms. Human genotyping provides data related to the genetic history of an individual; microorganism genotyping provide aid in research and development of bacterial and viral diseases. The increasing research and development activities in the healthcare sector, rising prevalence of genetic diseases, technological advancement, and surge in demand for personalized medication are expected to drive the growth of the genotyping market. Moreover, decreasing prices of genotyping services due to intense competition is contributing to the growth of the market. According to the Centers for Disease Control and Prevention (CDC), Genetic disorders are constantly increasing, and in the US more than 120000 babies are born with congenital disabilities, which are caused by genetic changes.
The uncertainty related to reimbursement and lack of skilled people may hamper the growth of the market during the assessment period.
Genotyping Market Segmentation
The Genotyping Market has been segmented on the basis of technology, product, application, and end-user.
On the basis of technology, the market has been classified as sequencing, capillary electrophoresis, PCR, microarray, and mass spectrometry. The sequencing segment has been further divided into next-generation sequencing, pyrosequencing, and Sanger sequencing. The Capillary electrophoresis segment has been further divided into amplified fragment length polymorphism (AFLP),single-strand conformation polymorphism (SSCP), and restriction fragment length polymorphism (RFLP). The microarray segment has been classified as DNA microarrays, antibody microarrays, MMChips, and peptide microarrays.
The product segment has been divided into reagents and kits, instruments, and services.
The application segment has been classified into diagnostics, drug discovery and development, agriculture, academic research, and personalized medicine.
The genotyping market, by end-user, has been segmented into hospitals, diagnostic centers, academic institutes, and research and development centers.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European genotyping market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Global Genotyping Market Share, by Region, 2017 (%)
Source: MRFR Analysis
The Americas are likely to dominate the global genotyping market owing to the well-established healthcare sector, increasing demand for personalized medicines, and a surge in research and development activities in the region. Moreover, increasing cases of genetic disorders is propelling the growth of the market. According to the report published by Alzheimer's Association in 2018, Prevalence of Alzheimer's disease is continuously increasing, and in the US 5.7 million Americans are living with the disease also it costs around USD 277 billion to the nation.
The European market is expected to be the second-largest genotyping market. The market growth in this region can be attributed to the increase in healthcare expenditure, government initiatives for increasing research and development in the region and increasing expenditure on R&D by pharmaceutical companies. According to the European Federation of Pharmaceutical Industries and Associations in 2015, pharmaceutical companies in the European region invested more than USD 38664 million in research and development activities.
Asia-Pacific is expected to be the fastest-growing genotyping market during the forecast period due to the increasing disposable income, favorable government policies, and rising investments in healthcare and expansions by market players in the region. For instance, in April 2018, Agilent Technologies, Inc. has opened a global solution development center in Singapore to provide services related to pharma, biopharma, lipidomic, and food testing.
The market in the Middle East & Africa is expected to account for the smallest share of the global genotyping market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Key Players
Some of the key players in the global genotyping market are QIAGEN, Affymetrix, Inc., Illumina, Inc, Thermo Fisher Scientific, Inc., General Electric Company, Agilent Technologies, Inc., Fluidigm Corporation, Sequenom, F. Hoffmann-La Roche Ltd, and Beckman Coulter, Inc.
The Market of Genotyping, by Technology
- Technology
- Sequencing
- Next-Generation Sequencing
- Pyrosequencing
- Sanger Sequencing
- Capillary Electrophoresis
- Amplified Fragment Length Polymorphism (AFLP)
- Single-Strand Conformation Polymorphism (SSCP)
- Restriction Fragment Length Polymorphism (RFLP)
- PCR
- Microarray
- DNA Microarrays
- Antibody Microarrays
- Mmchips
- Peptide Microarrays
- Mass Spectrometry
The Market of Genotyping, by Product
- Reagents and Kits
- Instruments
- Sequencer
- Amplifiers
- Services
The Market of Genotyping, by Application
- Diagnostics
- Drug Discovery and Development
- Academic Research
- Research and Development Centers
The Market of Genotyping, by End User
- Hospitals
- Diagnostic Centers
- Academic Institutes
- Research and Development Centers
The Market of Genotyping, by Region
- Americas
- North America
- US
- Canada
- South America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Intended Audience
- Biotechnology companies
- Bioinformatics service providers
- Medical devices manufacturers
- Bio supplier companies
- Genotyping product distributors and suppliers
- Healthcare providers
- Research institutes and academic centers
